Drug Profile
Research programme: neuropathic pain therapeutics - Kyowa Kirin
Alternative Names: Compound-ALatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Kyowa Hakko Kirin
- Developer Kyowa Kirin
- Class Small molecules
- Mechanism of Action Chemokine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Neuropathic-pain in Japan